Sg3 Management, LLC Vertex Pharmaceuticals Inc Call Options Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $3.76 Million - $4.68 Million	-16,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $3.54 Million - $4.18 Million	16,000 New	16,000 $4.18 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $8.16 Million - $9.13 Million	-45,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $6.56 Million - $7.74 Million	35,000 Added 350.0%	45,000 $9.07 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $2.56 Million - $3.03 Million	10,000 New	10,000 $2.72 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.